Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MDGL
MDGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MDGL News
Madrigal Pharmaceuticals Shares Enter Oversold Territory
2d ago
NASDAQ.COM
Ribo Life Science and Madrigal Sign siRNA Licensing Agreement
3d ago
PRnewswire
Ribo and Madrigal Sign Exclusive Global License Agreement
3d ago
PRnewswire
Ribo and Madrigal Announce Exclusive Global License Agreement
4d ago
PRnewswire
Madrigal Pharmaceuticals Enters $4.46B Licensing Deal with Suzhou Ribo
4d ago
seekingalpha
Ribo Life Science Enters Exclusive Licensing Agreement with Madrigal Pharmaceuticals
4d ago
PRnewswire
Ribo Life Science Enters Exclusive Licensing Agreement with Madrigal Pharmaceuticals
4d ago
PRnewswire
Ribo Enters Exclusive Licensing Agreement with Madrigal for siRNA Programs
4d ago
Newsfilter
Madrigal Pharmaceuticals Signs Exclusive Licensing Deal with Ribo Life Science
4d ago
stocktwits
Madrigal Pharmaceuticals Expands MASH Pipeline with New siRNA Programs
4d ago
Yahoo Finance
Sagimet Stock Increases Following Acne Treatment Success
Feb 03 2026
Barron's
AIG Stock Drops 10.05% Following Leadership Transition Announcement
Jan 11 2026
Benzinga
U.S. Markets Finished Higher on Friday; Sandisk Saw Notable Gains
Jan 09 2026
Barron's
Madrigal Secures Exclusive License from Pfizer for Ervogastat with $50M Upfront Payment
Jan 09 2026
Newsfilter
Madrigal Pharmaceuticals Downgraded to Hold, Shares Drop Over 5%
Jan 07 2026
NASDAQ.COM
Madrigal Pharmaceuticals Downgraded by Wolfe Research, Stock Drops Over 5%
Jan 07 2026
Fool
Show More News
